Andrew Garrett Campbell is an American biologist who is a professor of Medical Science and Dean of the Graduate School at Brown University.
[3] As a graduate student in 1986 Campbell partnered with fellow UCLA graduate student Theodore (Ted) B. Thederahn and UCLA graduate Robert B Laukka to serve as founding directors and principals of the Southern California-based research and radiation safety products manufacturing company, Bremshield Corporation whose products supported the U.S. academic biomedical research community and newly emerging biotech industry.
[5] As a postdoctoral Fellow in the laboratory of Dan S. Ray at UCLA, he began his studies of the endonuclease enzyme RNase H.[2] As a President's Postdoctoral Fellow at UCSF Campbell studied Hepatitis B Virus with William J. Rutter, founder of the Chiron Corporation which would go on to develop the Hepatitis B vaccine as the 1st genetically engineered vaccine to receive FDA approval for human use.
[6] In particular, Campbell continued his studies of the endonuclease enzymes Ribonuclease H (RNases H), with which he hopes to better understand nucleic acid metabolic function.
[7] He is also interested in the lifecycle of Trypanosoma brucei, a parasite carried by tsetse flies in sub-Saharan Africa.